Holobiome, founded by researchers, is a therapeutic company dedicated to treating diseases of the enteric and central nervous systems. The company's core mission is to harness the human microbiome to develop first-in-class therapies, translating emerging microbiome science into next-generation probiotics and targeted health solutions. Holobiome focuses on improving whole-body health through innovative microbiome-based treatments, particularly addressing mental health challenges.
Notable affiliated individuals include leading researchers in microbiome science. The company has garnered attention from significant investors and partners, reflecting confidence in its pioneering approach. Key achievements include the development of novel therapies that leverage gut microbes to tackle urgent medical challenges. Holobiome's impact lies in its potential to revolutionize treatments for mental and neurological health through microbiome science.
